Brief: GVS To Buy Haemonetics' Whole Blood Business For $44.6 Mln

GVS

03/12/2024 06:08

Dec 3 (Reuters) - GVS SpA  GVS.MI :
    * TO BUY HAEMONETICS' WHOLE BLOOD BUSINESS FOR $44.6 MILLION
    * ADDITIONAL USD 22.5 MILLION PAYABLE BY FEBRUARY 2029
    * TRANSACTION EXPECTED TO CLOSE IN Q1 2025
    * EXPECTED REVENUES EXCEEDING USD 50 MILLION IN FY 2025

Further company coverage:  GVS.MI 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))